查看購物車
  • Simplified Chinese
  • English
2021-2031年亞太地區類器官市場報告：範圍、細分、動態與競爭分析
市場調查報告書
商品編碼
1871518

2021-2031年亞太地區類器官市場報告：範圍、細分、動態與競爭分析

Asia Pacific Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 261 Pages | 訂單完成後即時交付

價格

預計亞太地區類器官市場將顯著成長，到 2031 年將達到約 23.271 億美元，高於 2023 年的 4.1914 億美元，預測期內年複合成長率(CAGR) 高達 23.9%。

執行摘要和市場分析

亞太地區的類器官市場涵蓋澳洲、中國、印度、日本、韓國等國。由於癌症發病率上升、對基因突變和癌症研究的需求增加、政府為提高公眾對人類類器官的認知而採取的舉措、有利於先進類器官產品開發和商業化的法規以及對類器官研究投入的增加等多種因素，預計該市場將快速成長。

市場區隔分析

亞太地區類器官市場可按類型、應用、來源、產品和方法進行細分：

  • 類型：市場依類器官類型分為腸道、肝臟、胃、胰臟、肺、腦、腎臟等。 2023年，腸道類器官佔了最大的市場。
  • 應用領域：主要應用包括發育生物學疾病、傳染病病理學、再生醫學、藥物毒性和療效測試、藥物研發以及個人化醫療。 2023年，發育生物學疾病領域佔最大佔有率。
  • 資料來源：市場分為多能幹細胞和器官特異性成體幹細胞，其中多能幹細胞在 2023 年佔據市場佔有率的主導地位。
  • 產品/服務：此部分包括儀器、耗材和服務，其中耗材在 2023 年佔據市場主導地位。儀器又分為設備和儀器，而耗材包括感測器和其他物品。
  • 方法：類器官發育所採用的方法包括微圖案板、超低附著板、懸滴法、微滴法或乳液法等，其中懸滴法在2023年佔據最大佔有率。

市場展望

個人化醫療，或稱精準醫療，是一種日益流行的趨勢，它根據患者的特定反應或疾病風險，量身定做醫療方案。這一趨勢正顯著推動亞洲地區類器官技術的研發和應用。例如，在中國，精準生物技術有限公司（ACCURATE International Biotechnology）已建立起全球最大的腫瘤類器官平台之一，擁有超過5000個模型，用於針對特定患者的藥物測試。與澳門大學等機構的合作，進一步推進了疾病建模和藥物反應的研究。

在日本，九州大學和名古屋大學等高校正將人工智慧與類器官開發相結合，在篩選用於治療的高品質類器官方面取得了很高的準確率。研究人員也正在探索基因編輯類器官在肝臟和神經系統疾病研究的應用。韓國2024年類器官開發者大會重點關注了再生醫學應用，專家們探討了類器官在潰瘍性結腸炎等疾病治療中的應用。新加坡正崛起為創新中心，Next&Bio與新加坡癌症科學研究所合作建立癌症類器官庫，以開發更有效的腫瘤療法，便是最好的例子。

藥劑師在推廣個人化醫療、提高公眾對精準治療的認知以及鼓勵製藥公司研發客製化療法方面發揮著至關重要的作用。個人化癌症醫療專注於基於腫瘤基因組特徵開發有效的治療策略。由於腫瘤類器官能夠準確預測藥物反應，相較於傳統模型具有顯著優勢，因此對個人化腫瘤建模的研究需求日益成長。

國家概況

亞太地區類器官市場涵蓋日本、中國、印度、韓國、澳洲和東南亞等主要國家，其中中國在2023年佔據最大的市場佔有率。中國市場的成長得益於研究的進步和個人化醫療的普及。腫瘤類器官的開發是一項重大突破，使研究人員能夠研究受腫瘤影響的各種組織和器官。

諸如Hubrecht Organoid Technology與華大基因青島株式會社的合作，旨在促進中國個人化醫療和治療的發展。此外，幹細胞研究經費的增加可望推動類器官的研發。

公司簡介

類器官市場的主要參與者包括STEMCELL Technologies Inc.、Molecular Devices、Hubrecht Organoid Technology、Definigen、Organoid Therapeutics、Thermo Fisher Scientific、Corning、Merck KGaA、InSphero、ACRO Biosystems、Bio-Techne、SUN bioscience、ORGANOID SCIY Biologics、3Dnamics和Cellesce。這些公司正透過擴張、產品創新和併購等策略來增強其市場佔有率並提供創新解決方案。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：

第4章：亞太地區類器官市場概況

  • PEST分析

第5章：亞太地區類器官市場－主要市場動態

  • 市場促進因素
    • 對腫瘤建模和生物樣本庫的需求日益成長
    • 個人化藥物的廣泛應用
  • 市場限制
    • 缺乏熟練的專業人才
  • 市場機遇
    • 重點關注藥物發現活動
  • 未來趨勢
    • 類器官與晶片器官的結合
  • 駕駛員和安全帶的影響：

第6章：類器官市場－亞太地區分析

  • 2021-2031年亞太地區類器官市場收入
  • 亞太地區類器官市場預測分析

第7章：亞太地區類器官市場分析－依類型分類

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第8章：亞太地區類器官市場分析－依應用領域分類

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和療效測試
  • 藥物發現與個人化醫療
  • 其他

第9章：亞太地區類器官市場分析－依來源分類

  • 多能幹細胞
  • 器官特異性成體幹細胞

第10章：亞太地區類器官市場分析－依產品/服務分類

  • 儀器
  • 消耗品
  • 服務

第11章：亞太地區類器官市場分析－依方法分類

  • 微圖案板
  • 超低附件板
  • 懸垂
  • 微滴或乳液
  • 其他

第12章：亞太地區類器官市場－國家分析

  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 越南
    • 印尼
    • 菲律賓
    • 亞太其他地區

第13章：行業概況

  • 概述
  • 類器官市場成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第14章：公司簡介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第15章：附錄

Product Code: TIPRE00018852

The Asia Pacific organoids market is projected to grow significantly, reaching approximately US$ 2,327.10 million by 2031, up from US$ 419.14 million in 2023, with a remarkable compound annual growth rate (CAGR) of 23.9% during the forecast period.

Executive Summary and Market Analysis

The organoids market in the Asia Pacific region includes countries such as Australia, China, India, Japan, South Korea, and others. The market is expected to expand rapidly due to several factors, including the rising incidence of cancer, increased demand for research on gene mutations and cancer, government initiatives to promote awareness of human organoids, supportive regulations for the development and commercialization of advanced organoid products, and heightened funding for organoid research.

Market Segmentation Analysis

The Asia Pacific organoids market can be segmented based on type, application, source, offering, and method:

  • Type: The market is divided into organoids from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoid segment held the largest market share.
  • Application: Key applications include developmental biology disease, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, and personalized medicine. The developmental biology disease segment was the largest in 2023.
  • Source: The market is categorized into pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells dominating the market share in 2023.
  • Offering: This segment includes instruments, consumables, and services, with consumables leading the market in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
  • Method: The methods used in organoid development include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion, and others, with the hanging drop method holding the largest share in 2023.

Market Outlook

Personalized medicine, or precision medicine, is a growing trend that tailors medical treatments to individual patients based on their specific responses or disease risks. This trend is significantly driving the development and application of organoid technologies across Asia. For instance, in China, ACCURATE International Biotechnology has created one of the largest tumor organoid platforms globally, featuring over 5,000 models for patient-specific drug testing. Collaborations with institutions like the University of Macau have further advanced research in disease modeling and drug responses.

In Japan, universities such as Kyushu and Nagoya are integrating artificial intelligence with organoid development, achieving high accuracy in selecting quality organoids for therapeutic applications. Researchers are also exploring gene-edited organoids to investigate liver and neurological disorders. South Korea's 2024 Organoid Developer Conference highlighted regenerative medicine applications, with experts discussing organoid use in treating conditions like ulcerative colitis. Singapore is emerging as a hub for innovation, exemplified by Next&Bio's partnership with the Cancer Science Institute of Singapore to develop a cancer organoid bank for more effective oncology therapies.

Pharmacists are crucial in promoting personalized medicine, raising awareness about precision treatments, and encouraging pharmaceutical companies to create tailored therapies. Personalized cancer medicine focuses on developing effective treatment strategies based on the genomic profiles of tumors. The demand for research in personalized tumor modeling is increasing, as tumor organoids can accurately predict drug responses, offering significant advantages over traditional models.

Country Insights

The Asia Pacific organoids market includes key countries such as Japan, China, India, South Korea, Australia, and Southeast Asia, with China holding the largest market share in 2023. The growth in China is driven by advancements in research and the popularity of personalized medicine. The development of tumor organoids has been a significant breakthrough, allowing researchers to study various tissues and organs affected by tumors.

Collaborations, such as the one between Hubrecht Organoid Technology and BGI-Qingdao, aim to enhance personalized care and treatment development in China. Additionally, increasing funding for stem cell research is expected to boost organoid research and development.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific, Corning, Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne, SUN bioscience, ORGANOID SCIENCES, Crown Bioscience, Sartorius, 3D Biotek, Prellis Biologics, 3Dnamics, and Cellesce. These companies are employing strategies such as expansion, product innovation, and mergers to enhance their market presence and offer innovative solutions.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Organoids Market Landscape

  • 4.1 PEST Analysis

5. Asia Pacific Organoids Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Surging Adoption of Personalized Drugs
  • 5.2 Market Restraints
    • 5.2.1 Dearth of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends
    • 5.4.1 Combination of Organoids and Organ-on-a-Chip
  • 5.5 Impact of Drivers and Restraints:

6. Organoids Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Organoids Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Organoids Market Forecast Analysis

7. Asia Pacific Organoids Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Organoids Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Organoids Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ-Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ-Specific Adult Stem Cell: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Organoids Market Analysis - by Offering

  • 10.1 Instruments
    • 10.1.1 Overview
    • 10.1.2 Instruments: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 Consumables
    • 10.2.1 Overview
    • 10.2.2 Consumables: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Services
    • 10.3.1 Overview
    • 10.3.2 Services: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Asia Pacific Organoids Market Analysis - by Method

  • 11.1 Micropatterned Plates
    • 11.1.1 Overview
    • 11.1.2 Micropatterned Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.2 Ultralow Attachment Plates
    • 11.2.1 Overview
    • 11.2.2 Ultralow Attachment Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.3 Hanging Drop
    • 11.3.1 Overview
    • 11.3.2 Hanging Drop: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.4 Microdroplet or Emulsion
    • 11.4.1 Overview
    • 11.4.2 Microdroplet or Emulsion: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. Asia Pacific Organoids Market - Country Analysis

  • 12.1 Asia Pacific
    • 12.1.1 Asia Pacific Organoids Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Asia Pacific Organoids Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.2.1 Japan: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.2.2 Japan: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.2.3 Japan: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.2.4 Japan: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.2.5 Japan: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.2.6 Japan: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.2.7 Japan: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.3 China: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.3.1 China: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.3.2 China: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.3.3 China: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.3.4 China: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.3.5 China: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.3.6 China: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.3.7 China: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.4 India: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.4.1 India: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.4.2 India: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.4.3 India: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.4.4 India: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.4.5 India: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.4.6 India: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.4.7 India: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.5 South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.5.1 South Korea: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.5.2 South Korea: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.5.3 South Korea: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.5.4 South Korea: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.5.5 South Korea: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.5.6 South Korea: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.5.7 South Korea: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.6 Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.6.1 Australia: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.6.2 Australia: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.6.3 Australia: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.6.4 Australia: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.6.5 Australia: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.6.6 Australia: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.6.7 Australia: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.7 Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.7.1 Singapore: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.7.2 Singapore: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.7.3 Singapore: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.7.4 Singapore: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.7.5 Singapore: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.7.6 Singapore: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.7.7 Singapore: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.8 Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.8.1 Thailand: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.8.2 Thailand: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.8.3 Thailand: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.8.4 Thailand: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.8.5 Thailand: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.8.6 Thailand: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.8.7 Thailand: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.9 Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.9.1 Malaysia: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.9.2 Malaysia: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.9.3 Malaysia: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.9.4 Malaysia: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.9.5 Malaysia: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.9.6 Malaysia: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.9.7 Malaysia: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.10 Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.10.1 Vietnam: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.10.2 Vietnam: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.10.3 Vietnam: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.10.4 Vietnam: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.10.5 Vietnam: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.10.6 Vietnam: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.10.7 Vietnam: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.11 Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.11.1 Indonesia: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.11.2 Indonesia: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.11.3 Indonesia: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.11.4 Indonesia: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.11.5 Indonesia: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.11.6 Indonesia: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.11.7 Indonesia: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.12 Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.12.1 Philippines: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.12.2 Philippines: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.12.3 Philippines: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.12.4 Philippines: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.12.5 Philippines: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.12.6 Philippines: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.12.7 Philippines: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.13 Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.13.1 Rest of APAC: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.13.2 Rest of APAC: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.13.3 Rest of APAC: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.13.4 Rest of APAC: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.13.5 Rest of APAC: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.13.6 Rest of APAC: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.13.7 Rest of APAC: Asia Pacific Organoids Market Share - by Method

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Organoids Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 STEMCELL Technologies Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Molecular Devices, LLC.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Organoid Therapeutics
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Thermo Fisher Scientific Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Corning Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Merck KGaA
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 InSphero
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 ACRO Biosystems.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Bio-Techne Corp
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 SUN bioscience SA
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments
  • 14.13 ORGANOID SCIENCES Co., Ltd.
    • 14.13.1 Key Facts
    • 14.13.2 Business Description
    • 14.13.3 Products and Services
    • 14.13.4 Financial Overview
    • 14.13.5 SWOT Analysis
    • 14.13.6 Key Developments
  • 14.14 Crown Bioscience Inc
    • 14.14.1 Key Facts
    • 14.14.2 Business Description
    • 14.14.3 Products and Services
    • 14.14.4 Financial Overview
    • 14.14.5 SWOT Analysis
    • 14.14.6 Key Developments
  • 14.15 Sartorius AG
    • 14.15.1 Key Facts
    • 14.15.2 Business Description
    • 14.15.3 Products and Services
    • 14.15.4 Financial Overview
    • 14.15.5 SWOT Analysis
    • 14.15.6 Key Developments
  • 14.16 3D Biotek LLC
    • 14.16.1 Key Facts
    • 14.16.2 Business Description
    • 14.16.3 Products and Services
    • 14.16.4 Financial Overview
    • 14.16.5 SWOT Analysis
    • 14.16.6 Key Developments
  • 14.17 Prellis Biologics Inc.
    • 14.17.1 Key Facts
    • 14.17.2 Business Description
    • 14.17.3 Products and Services
    • 14.17.4 Financial Overview
    • 14.17.5 SWOT Analysis
    • 14.17.6 Key Developments
  • 14.18 3Dnamics Inc.
    • 14.18.1 Key Facts
    • 14.18.2 Business Description
    • 14.18.3 Products and Services
    • 14.18.4 Financial Overview
    • 14.18.5 SWOT Analysis
    • 14.18.6 Key Developments
  • 14.19 Cellesce Ltd
    • 14.19.1 Key Facts
    • 14.19.2 Business Description
    • 14.19.3 Products and Services
    • 14.19.4 Financial Overview
    • 14.19.5 SWOT Analysis
    • 14.19.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners

List Of Tables

  • Table 1. Asia Pacific Organoids Market Segmentation
  • Table 2. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Offering
  • Table 7. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Method
  • Table 8. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 10. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 12. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 13. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 14. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 15. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 16. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 20. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 21. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 22. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 23. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 24. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 25. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 26. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 27. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 28. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 29. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 30. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 31. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 32. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 33. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 34. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 35. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 36. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 37. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 38. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 39. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 40. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 41. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 42. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 43. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 44. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 45. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 46. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 47. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 48. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 49. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 50. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 51. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 52. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 53. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 54. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 55. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 56. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 57. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 58. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 59. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 60. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 61. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 62. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 63. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 64. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 65. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 66. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 67. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 68. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 69. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 70. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 71. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 72. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 73. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 74. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 75. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 76. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 77. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 78. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 79. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 80. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 81. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 82. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 83. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 84. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 85. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 86. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 87. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 88. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 89. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 90. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 91. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 92. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 93. Recent Organic Growth Strategies in Organoids Market
  • Table 94. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Asia Pacific Organoids Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Asia Pacific Organoids Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 6. Asia Pacific Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Intestine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Liver: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Stomach: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Pancreas: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Lung: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Brain: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Kidney: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Asia Pacific Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 16. Developmental Biology Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Asia Pacific Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 23. Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Organ-Specific Adult Stem Cell: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Asia Pacific Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 26. Instruments: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Consumables: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Services: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Asia Pacific Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 30. Micropatterned Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Ultralow Attachment Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Hanging Drop: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Microdroplet or Emulsion: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Asia Pacific Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 36. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 39. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 40. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 41. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 42. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 43. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 44. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 45. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 46. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 47. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 48. Growth Strategies in Organoids Market